Revvity Inc (STU:PKN)
€ 114.55 0.5 (0.44%) Market Cap: 14.29 Bil Enterprise Value: 16.21 Bil PE Ratio: 61.12 PB Ratio: 1.96 GF Score: 78/100

Q3 2021 PerkinElmer Inc Earnings Call Transcript

Nov 02, 2021 / 09:00PM GMT
Release Date Price: €150.45 (-0.99%)
Operator

Good day, and thank you for standing by, and welcome to the PerkinElmer's Third Quarter 2021 Earnings Conference Call. (Operator Instructions). As a reminder, this conference is being recorded. (Operator Instructions).

I would now like to hand the conference over to your speaker today, Stephen Willoughby, Vice President of Investor Relations. Please go ahead.

Stephen Barr Willoughby
PerkinElmer, Inc. - VP of IR

Good afternoon, everyone, and welcome to PerkinElmer's Third Quarter 2021 Earnings Conference Call. On the call with me today are Prahlad Singh, our President and Chief Executive Officer; Jamey Mock, our Senior Vice President and Chief Financial Officer; and Peter Wrighton-Smith, Founder and Chief Executive of Oxford Immunotec.

If you have not yet received a copy of our earnings press release or slide presentation, you may find copies of them on the Investors section of our website at perkinelmer.com. Please note that this call is being webcast and will be archived on our website.

Before we begin, I'd like to remind everyone

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot